Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Lymphoma 4Hodgkin Disease 2Carcinoma, Non-Small-Cell Lung 2Small Cell Lung Carcinoma 1Lymphoma, Large B-Cell, Diffuse 1Leukemia, Myeloid, Acute 1Extensive Stage Small Cell Lung Cancer 1Congenital Abnormalities 1Central Nervous System Neoplasms 1Carcinoma, Small Cell 1Carcinoma, Neuroendocrine 1Burkitt Lymphoma 1Brain Neoplasms 1Blast Crisis 1Anemia, Refractory, with Excess of Blasts 1

Interventions

Temozolomide 53Bevacizumab 45Radiotherapy 28Radiosurgery 21Carboplatin 14Erlotinib Hydrochloride 11Radiation 10pembrolizumab 9Magnetic Resonance Spectroscopy 9Etoposide 9Vorinostat 8Trastuzumab 8Irinotecan 8Sunitinib 7Sorafenib 7Radiotherapy, Intensity-Modulated 7Lomustine 7Lapatinib 7Capecitabine 7dabrafenib 6Ipilimumab 6Imatinib Mesylate 6Cyclophosphamide 6Sirolimus 5Hydroxyurea 5Everolimus 5Bortezomib 5temsirolimus 4cabozantinib 4binimetinib 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Brain Neoplasms × Podophyllotoxin × Clear all
NCT00027846 2019-08-07

Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma

Children's Oncology Group

Phase 2 Completed
378 enrolled 16 charts
CNS

Brain Neoplasms, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡